CEN Biotech Inc (CENBF)
0.0031
0.00 (0.00%)
USD |
OTCM |
Apr 19, 15:13
CEN Biotech Debt to Equity Ratio: -1.847 for March 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2023 | -1.847 |
| December 31, 2022 | -2.167 |
| September 30, 2022 | -2.538 |
| June 30, 2022 | -2.850 |
| Date | Value |
|---|---|
| March 31, 2022 | -2.735 |
| December 31, 2021 | -3.153 |
| September 30, 2021 | -2.112 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-3.153
Minimum
Dec 2021
-1.847
Maximum
Mar 2023
-2.486
Average
-2.538
Median
Sep 2022
Debt to Equity Ratio Benchmarks
| Rimrock Gold Corp | -- |
| InMed Pharmaceuticals Inc | 0.00 |
| Venus Concept Inc | -5.346 |
| Juva Life Inc | 0.9671 |
| Lucy Scientific Discovery Inc | 14.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.447M |
| Total Liabilities (Quarterly) | 10.12M |
| Shareholders Equity (Quarterly) | -2.672M |
| Current Ratio | 0.03 |
| Net Debt Paydown Yield | 4.48% |